Today: 29 April 2026
Browse Category

NYSE:B 10 November 2025 - 30 January 2026

Barrick Mining stock drops before the bell as gold tumbles and JPMorgan weighs in

Barrick Mining stock drops before the bell as gold tumbles and JPMorgan weighs in

Barrick Mining shares fell 5.4% to $49.26 in premarket trading Friday after gold prices plunged over 8%, briefly dropping below $5,000 an ounce. JPMorgan initiated coverage with an Overweight rating and a $68 target ahead of Barrick’s Feb. 5 earnings. President Trump named Kevin Warsh as the next Fed chair, fueling market volatility. Barrick will appoint Helen Cai as CFO on March 1, replacing Graham Shuttleworth.
30 January 2026
···
Barrick Mining stock pops in premarket as gold breaks $5,100, with Fed and earnings looming

Barrick Mining stock pops in premarket as gold breaks $5,100, with Fed and earnings looming

Barrick Mining rose 3.6% to $52.93 in premarket trading Monday as gold hit a record above $5,100 an ounce. Investors await the Federal Reserve’s policy decision Jan. 28 and Barrick’s full-year results on Feb. 5. Barrick is reviewing a possible IPO for its North American gold assets but faces restrictions tied to its Nevada Gold Mines partnership with Newmont.
26 January 2026
····
Barrick Gold stock rises premarket as gold price steadies after sharp selloff

Barrick Gold stock rises premarket as gold price steadies after sharp selloff

Barrick Mining shares rose 1.1% in premarket trading Tuesday after a 4.7% drop the previous session. Spot gold gained 0.7% to $4,361.71 an ounce, rebounding from Monday’s 4.5% slide. Traders cited thin year-end liquidity and awaited the Federal Reserve’s December meeting minutes due later in the day. Barrick last closed at $44.02 and now trades under the NYSE ticker “B.”
30 December 2025
···
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX): Dec. 26, 2025 News, Forecasts and Analysis as Gold Hits New Records

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX): Dec. 26, 2025 News, Forecasts and Analysis as Gold Hits New Records

Gold hit a record $4,530.60 an ounce on December 26, boosting Barrick Mining shares, which last closed at $45.45 on December 24. Barrick is reviewing a potential IPO of its top North American gold assets, with an update expected in February. Signs of easing geopolitical risk in Mali are also supporting sentiment.
26 December 2025
····
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining shares are trading near the mid-$40s after gold hit a record $4,420 per ounce, up two-thirds in 2025. The easing of geopolitical risks in Mali and a strategic overhaul are also driving the stock. Barrick’s 12-month range swung from the mid-teens to mid-$40s. Wall Street forecasts gold could reach $4,900/oz by late 2026.
22 December 2025
···
Barrick Mining Corporation Stock (NYSE: B) News, Forecasts & Analysis for Dec. 12, 2025: Dividend, IPO Plans, and What’s Driving the Rally

Barrick Mining Corporation Stock (NYSE: B) News, Forecasts & Analysis for Dec. 12, 2025: Dividend, IPO Plans, and What’s Driving the Rally

Barrick Mining shares traded near a 52-week high of $43.94 on December 12, 2025, with market capitalization in the low $70 billion range. The stock’s surge follows rising gold prices, renewed institutional buying, and an expanded shareholder-return program. The company rebranded from Barrick Gold and changed its NYSE ticker to “B” in May. The next dividend date is December 15.
12 December 2025
··
Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Barrick Mining shares jumped to decade highs after the company said it will explore an IPO for a new unit holding its top North American gold assets. The stock closed near $42.33 on December 1, boosted by record gold prices and activist pressure from Elliott Management. Barrick reported record Q3 earnings, raised its dividend, and expanded its buyback program.
2 December 2025
···
Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining raised its base dividend 25% to $0.125 per share and expanded its share buyback by $500 million after reporting record Q3 operating and free cash flow. Net earnings for the quarter reached $1.3 billion on revenue of $4.1 billion. Gold production totaled 829,000 ounces, while copper output was 55,000 tonnes. Shares rose nearly 4% in premarket trading.
10 November 2025
····

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. (marketscreener.com) The revision matters because Biogen is
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop